Use of selected lactic acid bacteria for reducing infantile colic
AssigneeBiogaia AB
InventorsEamonn Connolly, Bo Mollstam
Life of this patent
Estimating the term…
Abstract
The invention herein provides certain strains of lactic acid bacteria selected for their capability of promoting production of IL-10 and consequently proliferation of CD4+CD25+ TR cells, for prophylaxis and/or treatment of infant colic, a method of selecting such strains, and products containing such strains.
Claims2
A method of reducing infantile colic, comprising ascertaining that an infant has been diagnosed with infantile colic in order to determine whether treatment for colic using a biologically pure culture of Lactobacillus rhamnosus is appropriate, and orally administering a prepared suspension of the biologically pure culture of Lactobacillus rhamnosus GG to the infant diagnosed with infantile colic.
Dependencies are inferred from the claim text.